BCL2 and hematologic disorder: On the other hand, a review study focused on the importance of BcL-2 for modulation of apoptosis at the mitochondrial level, its potential as a therapeutic target for hematological malignancies, and the results obtained with selective inhibitors of BH3-mimetics.